Synthetic long peptide-based vaccine formulations for induction of cell mediated immunity: A comparative study of cationic liposomes and PLGA nanoparticles

Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia

Gemma G. Kenter, Marij J.P. Welters, A. Rob P.M. Valentijn et al. · New England Journal of Medicine · 2009 · 1.1K citations · Full text

Medicine, Immunology, Oncology +17

Specific T Helper Cell Requirement for Optimal Induction of Cytotoxic T Lymphocytes against Major Histocompatibility Complex Class II Negative Tumors

Ferry Ossendorp, Erica Mengedé, Marcel Camps et al. · The Journal of Experimental Medicine · 1998 · 604 citations · Full text

Life Sciences, Immunology, Oncology +17

Established Human Papillomavirus Type 16-Expressing Tumors Are Effectively Eradicated Following Vaccination with Long Peptides

Sander Zwaveling, Sandra C. Ferreira Mota, Jan Nouta et al. · The Journal of Immunology · 2002 · 415 citations

Medicine, Immunology, Infectious Diseases +17

Phase I Immunotherapeutic Trial with Long Peptides Spanning the E6 and E7 Sequences of High-Risk Human Papillomavirus 16 in End-Stage Cervical Cancer Patients Shows Low Toxicity and Robust Immunogenicity

Gemma G. Kenter, Marij J.P. Welters, A. Rob P.M. Valentijn et al. · Clinical Cancer Research · 2008 · 309 citations · Full text

Medicine, Immunology, Oncology +17

CD8+ CTL Priming by Exact Peptide Epitopes in Incomplete Freund’s Adjuvant Induces a Vanishing CTL Response, whereas Long Peptides Induce Sustained CTL Reactivity

Martijn S. Bijker, Susan J. F. van den Eeden, Kees L. M. C. Franken et al. · The Journal of Immunology · 2007 · 282 citations

Life Sciences, Cancer Biology, Immunology +17